Effects of insulin-like growth factor-I on cultured human coronary artery smooth muscle cells

Growth Hormone and IGF Research

Volumn 13, Issue 5, 2003, Pages 246-253

  Bayes Genis, Antoni ^a,b   Schwartz, Robert S ^a   Bale, Laurie K ^a   Conover, Cheryl A ^a  

^a MAYO CLINIC   (United States)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

IGF I; Migration; Vascular smooth muscle cells

Indexed keywords

ALPHA5 INTEGRIN; BETA3 INTEGRIN; DISINTEGRIN; DNA; INTEGRIN RECEPTOR; KISTRIN; MITOGENIC AGENT; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY LM 609; NEUTRALIZING ANTIBODY; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ARTERY MUSCLE; ARTICLE; BINDING AFFINITY; CELL CULTURE; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY OBSTRUCTION; CROSS LINKING; DNA SYNTHESIS; HUMAN; HUMAN CELL; INHIBITION KINETICS; MEDICAL ASSESSMENT; MONOLAYER CULTURE; PRIORITY JOURNAL; RESTENOSIS; SMOOTH MUSCLE FIBER;

EID: 0141854293     PISSN: 10966374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1096-6374(03)00013-3     Document Type: Article

References (32)

1. R. Ross, The smooth muscle cell: growth of smooth muscle in cultures and formation of elastic fibers, J. Cell. Biol. 50 (1971) 172-186.
2. S.E. Epstein, C.B. Siegall, S. Biro, Y.M. Fu, D. Fitzgerald, I. Pastan, Cytotoxic effect of recombinant chimeric toxin on rapidly proliferating smooth muscle cells, Circulation 84 (1993) 778-787.
3. A. Bayes-Genis, C.A. Conover, R.S. Schwartz, Insulin-like growth factor axis: a review of atherosclerosis and restenosis, Circ. Res. 86 (2000) 125-130.
4. C.D. Stiles, G.T. Capone, C.D. Scher, H.N. Antoniades, J.J. Van Wyk, W.J. Pledger, Dual control of cell growth by somatomedins and platelet-derived growth factor, Proc. Natl. Acad. Sci. USA 76 (1979) 1279-1283.
5. D.R. Clemmons, J.J. vanWyk, Evidence for a functional role of endogenously produced somatomedin-like peptides in the regulation of DNA synthesis in cultured human fibroblasts and porcine smooth muscle cells, J. Clin. Invest. 75 (1985) 1914-1918.
6. C. Schriever, A. Schmidt, G. Breithardt, E. Buddecke, Human recombinant insulin-like growth factor I and -II stimulate the expression of basic fibroblast growth factor but suppress the division of bovine coronary smooth muscle cells, Atherosclerosis 122 (1996) 255-263.
7. S. Topouzis, M.W. Majesky, Smooth muscle lineage diversity in the chick embryo: two types of aortic smooth muscle cell differ in growth and receptor-mediated transcriptional responses to transforming growth factor-β, Dev. Biol. 178 (1996) 430-445.
8. R. Ross, B. Kariya, Morphogenesis of vascular smooth muscle in atherosclerosis and cell culture, in: D.F. Bohr, A.P. Somlyo, H.V. Sparks (Eds.), Handbook of Physiology: the Cardiovascular System II. Circulation, Vascular Smooth Muscle, American Physiological Society, Bethesda, MD, 1980, pp. 69-91.
9. C.A. Conover, J.T. Clarkson, L.K. Bale, Insulin-like growth factor-II enhancement of human fibroblast growth via a nonreceptor-mediated mechanism, Endocrinology 135 (1994) 76-82.
10. C.A. Conover, L.C. Hartmann, S. Bradley, P. Stalboerger, G.G. Klee, K.R. Kalli, R.B. Jenkins, Biological characterization of human epithelial ovarian carcinoma cells in primary culture: the insulin-like growth factor system, Exp. Cell. Res. 238 (1998) 439-449.
11. 3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor, Proc. Natl. Acad. Sci. USA 93 (1996) 2482-2487.
12. R.R. Burk, A factor from transformed cell line that affects migration, Proc. Natl. Acad. Sci. USA 70 (1973) 369-372.
13. C.A. Conover, P.D.K. Lee, B.L. Riggs, D.R. Powell, Insulin-like growth factor-binding protein-1 expression in cultured human bone cells: regulation by insulin and glucocorticoid, Endocrinology 137 (1996) 3295-3301.
14. F. Jiang, T.J. Frederick, T.L. Wood, IGF-I synergizes with FGF-2 to stimulate oligodendrocyte progenitor entry into the cell cycle, Dev. Biol. 232 (2001) 414-423.
15. P. Chieffi, A. Picascia, R. Stanzione, G. Villone, D. Tramontano, Endogenous insulin-like growth factors regulate the proliferation of TSH-independent mutants derived from FRTL5 cells, Biochimie 81 (1999) 367-371.
16. R. Ross, The pathogenesis of atherosclerosis: a perspective from the 1990s, Nature 362 (1993) 801-809.
17. A.W. Clowes, S.M. Schwartz, Significance of quiescent smooth muscle migration in the injured rat carotid artery, Circ. Res. 56 (1985) 139-145.
18. D.K. Kaul, H.M. Tsai, X.D. Liu, M.T. Nakada, R.L. Nagel, B.S. Coller, Monoclonal antibodies to αVβ3 (7E3 and LM609) inhibit sickle red blood cell-endothelium interactions induced by platelet-activating factor, Blood 15 (2000) 368-374.
19. D. LeRoith, H. Werner, D. Beitner-Johnson, C.T. Roberts, Molecular and cellular aspects of the insulin-like growth factor I receptor, Endocrinol. Rev. 16 (1995) 143-163.
20. M.J. Khorsandi, J.A. Fagin, D. Gianella-Neto, J.S. Forrester, B. Cercek, Regulation of insulin-like growth factor-I and its receptor in rat aorta after balloon denudation: evidence for local bioactivity, J. Clin. Invest. 90 (1992) 1926-1931.
21. J. Wang, W. Niu, Y. Nikiforov, S. Naito, S. Chernausek, D. Witte, D. LeRoith, A. Strauch, J.A. Fagin, Targeted overexpression of IGF-I evokes distinct patterns of organ remodeling in smooth muscle cell tissue beds of transgenic mice, J. Clin. Invest. 100 (1997) 1425-1439.
22. B.L. Wolfe, C.B. Rich, H.D. Goud, A.J. Terpstra, M. Bashir, J. Rosenbloom, G.E. Sonensheim, J.A. Foster, Insulin-like growth factor I regulates transcription of the elastin gene, J. Biol. Chem. 268 (1993) 12418-12426.
23. K.E. Bornfeldt, E.W. Rainco, T. Nateano, L.M. Groves, E. Krebs, R. Ross, Insulin-like growth factor I and platelet derived growth factor BB directed migration of human arterial smooth muscle cells via signalling pathways that are distinct from those of proliferation, J. Clin. Invest. 93 (1993) 1266-1274.
24. A. Gockerman, T. Prevette, J.I. Jones, D.R. Clemmons, Insulin-like growth factor (IGF)-binding proteins inhibit the smooth muscle cell migration responses to IGF-I and IGF-II, Endocrinology 136 (1995) 4168-4173.
25. Y. Imai, D.R. Clemmons, Roles of phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways in stimulation of vascular smooth muscle cell migration and deoxyribonucleic acid synthesis by insulin-like growth factor-I, Endocrinology 140 (1999) 4228-4235.
26. 3 and osteopontin expression during neointima formation, Cardiovasc. Res. 36 (1997) 408-428.
27. J.H. Baron, E.P. Moiseeva, D.P. de Bono, K.R. Abrams, A.H. Gershlick, Inhibition of vascular smooth muscle cell adhesion and migration by c7E3 Fab (abciximab): a possible mechanism for influencing restenosis, Cardiovasc. Res. 48 (2000) 464-472.
28. The ERASER Investigators, Acute platelet inhibition with abciximab does not reduce instent restenosis (ERASER study), Circulation 100 (1999) 799-806.
29. R. Ross, Atherosclerosis - an inflammatory disease, N. Engl. J. Med. 340 (1999) 115-126.
30. C. LeLievre, N.M. LeDouarin, Mesenchymal derivatives of the neural crest: analysis of chimeric quail and chick embryos, J. Embryol. Exp. Morphol. 34 (1975) 125-154.
31. T.H. Rosenquist, A. Beall, Elastogenic cells in the developing cardiovascular system: smooth muscle, non-smooth muscle and cardiac neural crest, Ann. N.Y. Acad. Sci. 588 (1990) 106-119.
32. T. Mikawa, R. Gourdie, Pericardial mesoderm generates a population of coronary smooth muscle cells migrating into the heart along with ingrowth of the epicardial organ, Dev. Biol. 174 (1996) 221-232.